Thomas McCauley
CIK: 0001858760
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
STOK
Stoke Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About McCauley Thomas
McCauley Thomas (SEC CIK 0001858760) files insider reports with the SEC as Chief Scientific Officer of Stoke Therapeutics, Inc. (STOK).
Signal8 holds 2 ownership filings by McCauley Thomas (1 Form 3, 1 Form 4), filed on Jul 17, 2026. Those filings report 1 transaction, the latest on Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on McCauley Thomas's filings is in BEDFORD, MA.
Recent filings by McCauley Thomas
- Jul 15, 2026: Grant or award of STOK derivative securities (Form 4, code A).
Other insiders filing for Stoke Therapeutics, Inc. (STOK)
- Allan Jonathan, GENERAL COUNSEL & CORP SEC
- Ticho Barry, CHIEF MEDICAL OFFICER
- Cumbo Alexander, Director
- Kaye Edward M. MD, Director
- Harrison Seth Loring, Director
- TZIANABOS ARTHUR, Director